National Institute for Health and Clinical Excellence (NICE)
Self-harm is everyone’s business, NICE says in new draft guideline
All professionals working across the health and social care system have a role to play in supporting people who self-harm and the issue should not just be seen as the responsibility of those with mental health expertise, NICE has said in a new draft guideline.
In the first new guideline for 11 years looking at self-harm, the independent NICE committee has drawn up new recommendations for people working in settings from primary care to psychiatry.
The assessment, management and preventing recurrence of self-harm guideline provides information, for the first time, for people working in education and criminal justice settings.
The new guideline sets out the responsibilities of non-mental health specialists when caring for people who self-harm. This includes health and social care professionals working in primary care, non-mental health emergency department professionals, those working in general hospital settings and in social care. There are also recommendations for ambulance staff and paramedics.
The guideline calls for non-specialists who have provided initial care to organise a comprehensive psychosocial assessment, at the earliest opportunity after an episode of self-harm, and that this should be carried out by a specialist mental health professional.
The aim of the comprehensive psychosocial assessment is to:
- develop a relationship with the person
- begin to understand why the person has self-harmed
- ensure that the person receives the care they need
- gives the person and their family members or carers information about their condition and diagnosis.
Self-harm is defined as intentional self-poisoning or injury irrespective of the apparent purpose of the act.
Only a minority of people who have self-harmed present to hospital services, but it remains one of the commonest reasons for hospital attendance. Some estimates suggest upwards of 200,000 presentations in England every year, the majority for self-poisoning.
While prevalence statistics are unreliable because it is a problem that is sometimes hidden, a recent national study reported that 7.3% of girls, and 3.6% of boys, aged 11 to 16, had self-harmed or attempted suicide at some point. The figures for 17- to 19-year-olds were 21.5% for girls and 9.7% for boys.
Self-harm can occur at any age, but there is evidence that there has been a recent increase in self-harm among young people in England.
For some people, self-harm is a one-off episode but repetition is also common, with 20% of people repeating self-harm within a year.
People who have self-harmed are at greatly increased risk of suicide, with a 30- to 50-fold increase in risk in the year after hospital presentation.
Dr Paul Chrisp, director of the centre for guidelines at NICE, yesterday said:
“Self-harm is a growing problem and should be everyone’s business to tackle – not just those working in the mental health sector.
“It is important that our committee has made recommendations for education and criminal justice settings as data in the past few years has shown that people working within these sectors would benefit from clear guidance about how they should help someone who is self-harming.
“These guidelines set out a way for every person who self-harms to be able to get the support and treatment they need.”
The guideline recommends offering a cognitive behavioural therapy (CBT)-based psychological intervention that is specifically structured for adults who self-harm.
For children and young people with significant emotional dysregulation difficulties who have frequent episodes of self-harm, mental health professionals should consider treating them with a dialectical behaviour therapy adapted for adolescents (DBT-A).
Professor Nav Kapur, topic advisor for the self-harm guideline and professor of psychiatry and population health at the University of Manchester yesterday said:
“Self-harm can occur at any age and present to any setting.
“Historically, people who have harmed themselves have had a highly variable experience of services. This new guideline is an opportunity to make things better, particularly from the point of view of assessment and aftercare.”
A public consultation has now begun on the recommendations via nice.org.uk until Tuesday 1 March.
Latest News from
National Institute for Health and Clinical Excellence (NICE)
NICE recommends offering app-based treatment for people with insomnia instead of sleeping pills20/05/2022 12:10:00
Hundreds of thousands of people suffering from insomnia who would usually be prescribed sleeping pills could be offered an app-based treatment programme instead, NICE has said
Draft NICE guidance recommends innovative technology used to establish whether breast cancer has spread17/05/2022 12:15:00
A magnetic marker liquid injected into people with invasive breast cancer will help surgeons discover if the cancer has spread, after the technology was recommended in draft NICE guidance
More than 400 people could benefit from life-extending advanced lung cancer treatment after it was recommended for routine use on the NHS17/05/2022 11:15:00
Durvalumab recommended as an option for treating non-small-cell lung cancer (NSCLC).
Women with moderate to severe fibroids set to be offered new one-a-day treatment following final draft guidance from NICE16/05/2022 14:15:00
Around 4,500 women with uterine fibroids will be eligible for a new oral treatment after NICE recommended relugolix with estradiol and norethisterone acetate (also called Ryeqo and made by Gedeon Ritcher UK) in final draft guidance.
NICE outlines steps needed to put ME/CFS guideline into practice12/05/2022 16:10:00
NICE has today, International ME Awareness Day (Thursday, 12 May 2022) published its implementation statement which sets out the practical steps needed to put its recent guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS) into
Healthier lifestyle can help to ease osteoarthritis symptoms says NICE03/05/2022 16:15:00
Exercise has an important role to play in helping people living with osteoarthritis NICE says in draft updated guidelines published recently (29th April 2022) on the care and management of people with the condition.
Over 700 people a year could benefit from a new potentially life-extending lung cancer drug which targets a specific genetic mutation14/04/2022 16:10:00
New potentially life-extending lung cancer drug which targets a specific genetic mutation recommended by NICE.
NICE reaches important milestone in the UK’s efforts to tackle antimicrobial resistance.13/04/2022 11:15:00
Two new antimicrobial drugs – cefiderocol and ceftazidime–avibactam – are close to becoming the first to be made available as part of the UK’s innovative subscription-style payment model after NICE yesterday (Tuesday, 12 April 2022) published draft guidance estimating their value to the NHS.